Integrative Pain Management for Chronic Pain
(IPMP+ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore new ways to manage chronic pain in low-income, racially, and ethnically diverse individuals. Researchers are testing two main treatments: group acupuncture, which uses needles to stimulate specific points on the body, and integrative group medical visits that include education on pain, physical movement, mindfulness training, and peer support. The goal is to find more effective, non-drug methods to help those who feel isolated and face challenges in pain care. Individuals with chronic pain for more than three months, who have recently seen a primary care doctor for their pain, and can join group sessions might be a good fit for this study. As an unphased trial, this study offers a unique opportunity to contribute to innovative pain management solutions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both group acupuncture and integrative group medical visits (IGMV) are generally well-tolerated by patients. Group acupuncture effectively reduces pain and improves physical function without serious side effects. Patients often feel relaxed after treatments, and side effects, such as minor bruising, are rare.
IGMV combines education and support with various non-drug therapies. Participants learn to manage pain through lifestyle changes and receive support from others with similar experiences. Studies suggest this method is safe and helps improve pain management without significant negative effects.
Overall, both treatments have shown promise in improving pain and are considered safe based on past research.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for chronic pain because they incorporate holistic approaches that go beyond typical pain management strategies like medication and physical therapy. Group Acupuncture offers tailored acupuncture sessions in a community setting, which may enhance both physical and emotional well-being through social support and traditional Chinese medicine techniques. Integrative Group Medical Visits (IGMV) take a comprehensive approach by combining education on pain management, mindfulness, and peer support, all within a structured 12-week program. This combination not only addresses physical symptoms but also targets mental and social aspects of chronic pain, aiming to provide a more rounded and sustainable relief option compared to standard care.
What evidence suggests that this trial's treatments could be effective for chronic pain?
Research has shown that integrative group medical visits (IGMV), one of the treatments in this trial, can help manage chronic pain. One study found that these visits reduced the need for pain medication and improved overall well-being. Participants in IGMV reported better physical and mental health, experiencing less pain and improved social interactions.
For group acupuncture, another treatment option in this trial, studies indicate it can greatly reduce pain and enhance physical abilities. After three months of group acupuncture, about 30% of participants reported a significant decrease in how much pain affected their daily lives. Both treatments offer promising options for managing chronic pain, and this trial will evaluate their effectiveness.13567Who Is on the Research Team?
Maria Chao, DrPH, MPA
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for individuals from low-income backgrounds who are experiencing chronic pain and receive care at primary safety net clinics. It aims to help those affected by social isolation, stigma, and disparities in pain management.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Integrative Group Medical Visits (IGMV), group acupuncture, both, or usual care for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Final Follow-up
Final assessment of outcomes including pain impact and social support
What Are the Treatments Tested in This Trial?
Interventions
- Group Acupuncture
- Integrative Group Medical Visits
Group Acupuncture is already approved in United States, European Union, China, Canada for the following indications:
- Chronic Pain Management
- Pain Relief
- Pain Management
- Migraines
- Tension Headaches
- Chronic Pain
- Neck Pain
- Back Pain
- Migraines
- Pain Relief
- Chronic Pain Management
- Migraines
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator